Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

193 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

NCT00015951

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

NCT01295710

Conditions
Adult Acute Lymphoid Leukemia, Adult Acute Myeloid Leukemia, Anemia, +19 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Medical Center, BMT Stanford, California, United States
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 28 locations
View Trial Details
Completed

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

NCT02208037

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +35 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Completed

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

NCT01868477

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +6 more
Locations
  • Novartis Investigative Site Oran, Algeria
  • Novartis Investigative Site Sidi Bel Abbes, Algeria
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site La Plata, Buenos Aires, Argentina
View all 30 locations
View Trial Details
Completed

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes

NCT00352001

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Cleveland Clinic Taussig Cancer Instititute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details

Related conditions